1.Exploration of Clinical Thoughts for Treatment of Stable Angina with Insomnia under the Guidance of the "Blood-Pulse-Heart-Spirit"
Xinbiao FAN ; Zhipeng YAN ; Xiaofei GENG ; Lu LIAN ; Binbin DING ; Aolin LI ; Junping ZHANG
Journal of Traditional Chinese Medicine 2024;65(12):1240-1244
Guided by the concept of "blood-pulse-heart-spirit", it is believed that stable angina combined with insomnia is caused by disturbance of blood vessels, which leads to loss of nourishment for the heart body and heart spirit, so the core treatment principle is to regulate the blood vessels and calm the mind. At the beginning of the disease, it shows as the liver fails to govern the free flow of qi, and disorders qi and blood; during the progress of the disease, it shows as spleen deficiency and phlegm stagnation, phlegm and blood stasis obstructing the vessels; the central mechanism of the disease shows as disturbance of blood vessels and insufficient heart yin. For the pattern of liver depression and blood stasis, pattern of phlegm and blood stasis blocking the vessels, and pattern of heart yin deficiency, it is recommended to treat by Wuzang Shenning Formula (五脏神宁方) to dredge the liver and regulate the vessels, Banxia Houpo Decoction (半夏厚朴汤) plus Gualou Xiebai Banxia Decoction (瓜蒌薤白半夏汤) to dissolve phlegm and regulate the vessels, and Yunpi Tiaoxin Decoction (运脾调心汤) to nourish the yin and regulate the vessels. Throughout the treatment, pattern differentiation and treatment is accompanied by the method of calming the mind with heavy sedatives and nourishing the blood to calm the mind, so as to achieve the purpose of regulating mind and heart together and treating the body and spirit at the same time.
2.Stable Angina Pectoris with Sleep Disorders Treated by Modified Tongmai Anshen Formula (通脉安神方加减): An Clinical Observation of 74 Cases
Xinbiao FAN ; Xiaofei GENG ; Zhipeng YAN ; Tingting LI ; Yajie FAN ; Aolin LI ; Wenyu SHANG ; Chi ZHANG ; Junping ZHANG
Journal of Traditional Chinese Medicine 2023;64(17):1777-1785
ObjectiveTo observe the clinical efficacy of the Modified Tongmai Anshen Formula (通脉安神方加减, MTAF) in the treatment of stable angina pectoris (SAP) with sleep disorders. MethodsA total of 148 patients suffering from SAP with sleep disorder were included and randomly divided into control group and treatment group, with 74 patients in each group. The control group received conventional western medicine, and the treatment group additionally received MTAF (1 dose per day), both for 4 weeks. The changes in angina pectoris symptoms, traditional Chinese medicine (TCM) syndromes, sleep quality, quality of life, serological indicators including serum intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), brain-derived nerve growth factor (BDNF) and tyrosine kinase receptor B (TrkB) were compared between groups before and after treatment, and the safety was evaluated. ResultsIn the treatment group and the control group, the total effective rates of TCM syndromes(82.43% vs 52.70%), angina pectoris (79.73% vs 64.86%) and sleep (89.19% vs 68.92%) showing significant difference (P<0.001). After treatment, the total TCM syndrome score, primary symptom score, secondary symptom score, and secondary symptoms sleeplessness, restlessness, tiredness and fatigue individual score, angina pectoris score, PSQI total score and each item score were all significantly reduced in both groups, while the SF-36 single item score significantly increased (P<0.05). The total TCM syndromes and primary symptom scores, secon-dary symptoms sleeplessness, restlessness, tiredness and fatigue individual score, angina pectoris score, time to fall asleep, sleep quality, hypnotic medication, sleep disturbance, daytime dysfunction score and PSQI total score were significantly lower in the treatment group than those in the control group after treatment (P<0.05), while the somatic pain, general health status, social functioning, emotional functioning, mental health, and health change were significantly higher in the treatment group (P<0.05). After treatment, ICAM-1 and VCAM-1 level significantly decreased (P<0.05), and BDNF and TrkB levels increased (P<0.05) in the treatment group, while BDNF level significantly decreased in the control group (P<0.05). The TrkB level was significantly higher in the treatment group compared to the control group after treatment (P<0.05). A total of four adverse events occurred during the treatment, none of which were considered to be related to this study. ConclusionMTAF can significantly improve angina pectoris symptoms, TCM syndromes, sleep quality and quality of life in patients suffering from SAP with sleep disorders, the mechanism of which may be related to the protection of vascular endothelial function and central neurons.